Skip to main content
. 2008 Oct;19(10):2001–2010. doi: 10.1681/ASN.2007121272

Table 4.

Changes of immune parameters from the beginning of the study to the last follow-up

Variable Multitarget IVCY Difference (95% CI) P
Negative conversion ratio of Anti-dsDNA 6/12 (50.0%) 4/12 (33.3%) 16.7% (−22.2% to 55.5%) 0.680
Normalization rate of serum C3 11/20 (55.0%) 8/19 (42.1%) 12.9% (−18.2% to 44.0%) 0.527